Suchergebnisse - "Pinter, Matthias"

PubPharm (218)

1

Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient

enthalten in: Journal of hepatology | 2024

von Jachs, M. | Hartl, L. | Simbrunner, B. | +10

2

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Dominik, N. | Scheiner, B. | Zanetto, A. | +14

3

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

enthalten in: Journal of hepatology | 2024

von Celsa, C. | Cabibbo, G. | Fulgenzi, C. | +69

4

Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion

enthalten in: Cancer imaging : the official publication of the International Cancer Imaging Society | 2024

von Balcar, L. | Mrekva, A. | Scheiner, B. | +7

5

A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma

enthalten in: JHEP reports : innovation in hepatology | 2024

von Balcar, L. | Scheiner, B. | Fulgenzi, C. | +45

6

Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD

enthalten in: JHEP reports : innovation in hepatology | 2024

von Balcar, L. | Simbrunner, B. | Paternostro, R. | +12

CommentIn: JHEP Rep. 2023 Nov 27;6(1):100967. - PMID 38089548

7

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma : a multicentre retrospective study

enthalten in: The Lancet. Oncology | 2023

von Zeng, Q. | Klein, C. | Caruso, S. | +119

8

Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome

enthalten in: Hepatology international | 2023

von Simbrunner, B. | Villesen, I. | Scheiner, B. | +12

9

Analysis of individual patient data in patients with HCC treated with immunotherapy : A step forward for clinical trial design

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Pinter, M. | Reig, M. | Cabibbo, G.

10

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050) : a randomised, open-label, multicentre, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Qin, S. | Chen, M. | Cheng, A. | +122

CommentIn: Lancet. 2023 Nov 18;402(10415):1806-1807. - PMID 37883983

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]